SubtleGAD™
AI-powered for safer MRI*

At Subtle Medical, we’re dedicated to developing innovative healthcare solutions that put patient safety and wellbeing first. SubtleGAD™ (currently in investigational stage) is a software that uses state of the art deep learning technology to enable a 90% dose reduction of GBCA’s for contrast-enhanced MRI while maintaining excellent image quality.

SubtleGAD™ is being developed to provide a potentially safer option for patients who need to undergo MRI exams by reducing the necessary gadolinium dose by up to 1/10th of the standard dose. The software infrastructure is being built to seamlessly integrate between any brand of MR scanner and PACS.

Subtle Medical was awarded a $1.6 Million SBIR Grant in 2019 to conduct research on SubtleGAD™. In 2020, Phase II funding was awarded based on the results achieved during Phase I, as well as the scientific and technical merit of the project.

About Subtle Medical

Subtle Medical, Inc. is a healthcare technology company with deep learning solutions that increase the quality and efficiency of medical imaging. It was named CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner. Current clinical partners include UCSF, Hoag Hospital, Mount Sinai, Sickkids, Radnet, DASA, Tiantan Hospital, and Middlesex Hospital, among others. Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, GE Healthcare, Philips (China) and several pharmaceutical partners. For more information, please visit subtlemedical.com or email sales@subtlemedical.com.

*Information on this page is for research, scientific, and educational purposes. All statements, data and results presented in these publications should be considered for investigational use.